Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232Eric Larsen, William L. Carroll, Alisa L. Eicher et al.|Journal of Clinical Oncology|2016Cited by 380
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232Michael J. Borowitz, Eric Larsen, Brent L. Wood et al.|Blood|2015Cited by 356
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupShalini C. Reshmi, Stephen P. Hunger, Richard C. Harvey et al.|Blood|2017Cited by 305
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C. Widemann, Frank M. Balis, Eva Dombi et al.|Neuro-Oncology|2014Cited by 114